Russo RIC, Beguelin W, Flaque MCD, Proietti CJ, et al. Correction: Targeting ErbB-2 nuclear localization and function inhibits breast cancer growth and overcomes trastuzumab resistance. Oncogene 2023 Sep 8. doi: 10.1038/s41388-023-02832.
PMID: 37684410